ergotamine and Pernicious Vomiting of Pregnancy

ergotamine has been researched along with Pernicious Vomiting of Pregnancy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Airola, G; Allais, G; Benedetto, C; Bosio, A; Ciochetto, D; De Lorenzo, C; Mana, O; Quirico, PE; Terzi, MG	1

Reviews

1 review(s) available for ergotamine and Pernicious Vomiting of Pregnancy

Article	Year
[Migraine during pregnancy and lactation: treatment of the acute attack and non-pharmacological prophylactic strategies]. Minerva medica, 2003, Volume: 94, Issue:4 Suppl 1 Topics: Abnormalities, Drug-Induced; Acetaminophen; Acupuncture Points; Acupuncture Therapy; Adult; Analgesics; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Aspirin; Biofeedback, Psychology; Controlled Clinical Trials as Topic; Domperidone; Ergotamine; Female; Fetus; Humans; Hyperemesis Gravidarum; Infant, Newborn; Lactation; Migraine Disorders; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Prognosis; Relaxation Therapy; Risk Factors; United States; United States Food and Drug Administration; Vasoconstrictor Agents	2003

Article

Year

[Migraine during pregnancy and lactation: treatment of the acute attack and non-pharmacological prophylactic strategies].

Minerva medica, 2003, Volume: 94, Issue:4 Suppl 1

Topics: Abnormalities, Drug-Induced; Acetaminophen; Acupuncture Points; Acupuncture Therapy; Adult; Analgesics; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Aspirin; Biofeedback, Psychology; Controlled Clinical Trials as Topic; Domperidone; Ergotamine; Female; Fetus; Humans; Hyperemesis Gravidarum; Infant, Newborn; Lactation; Migraine Disorders; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Prognosis; Relaxation Therapy; Risk Factors; United States; United States Food and Drug Administration; Vasoconstrictor Agents

2003